Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch
  

Csl Behring Gmbh patents

Recent patent applications related to Csl Behring Gmbh. Csl Behring Gmbh is listed as an Agent/Assignee. Note: Csl Behring Gmbh may have other listings under different names/spellings. We're not affiliated with Csl Behring Gmbh, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "C" | Csl Behring Gmbh-related inventors




Date Csl Behring Gmbh patents (updated weekly) - BOOKMARK this page
09/28/17Sugar compositions for treating hemophilia a and/or von willebrand disease
07/27/17Improved factor viii preparations suitable for therapeutic use and processes to obtain these
05/25/17Method of purifying therapeutic proteins
05/18/17Inhibitory anti-factor xii/xiia monoclonal antibodies and their uses
05/04/17Inhibitory anti-factor xii/xiia monoclonal antibodies and their uses
04/27/17Therapy using a factor xii inhibitor in a neurotraumatic disorder
03/23/17Modified coagulation factor viia with extended half-life
09/29/16Factor xii inhibitors for the administration with medical procedures comprising contact with artificial surfaces
06/16/16Combination therapy using a factor xii inhibitor and a c-1 inhibitor
01/14/16Therapeutic agent for amniotic fluid embolism
01/14/16Treatment and prevention of remote ischemia-reperfusion injury
01/14/16Proteolytically cleavable fusion proteins with high molar specific activity
12/24/15A purifying therapeutic proteins
06/04/15Methods to reduce adverse events caused by pharmaceutical preparations comprising plasma derived proteins
03/26/15Sugar compositions for treating hemophilia a and/or von willebrand disease
01/22/15Combined use of a sulfated glycosaminoglycan and a hyaluronidase for improving the bioavailability of factor viii
12/25/14Factor xii inhibitors for the treatment of neurological inflammatory disorders
12/18/14Use of c1-inhibitor for the treatment of secondary edema of the central nervous system
12/04/14Modified coagulation factor viia with extended half-life
09/18/14Modified coagulation factors with prolonged in vivo half-life
09/04/14Therapeutic polypeptides with increased in vivo recovery
05/08/14Von willebrand factor or factor viii and von willebrand factor for the treatment of coagulopathy induced by inhibitors of thrombocytes
04/03/14Methods for purification of alpha-1-antitrypsin and apolipoprotein a-1
03/13/14Factor viii, von willebrand factor or complexes thereof with prolonged in vivo half-life
12/19/13Therapeutic polypeptides with increased in vivo recovery
10/31/13Methods for purification of alpha-1-antitrypsin and apolipoprotein a-1
07/11/13Ancestral serine protease coagulation cascade exerts a novel function in early immune defense
06/27/13Treatment of diseases linked to pathological kinin formation
05/09/13Holder for an injection syringe
01/03/13Synergistic therapeutic use of prothrombin complex concentrates with fvlll concentrates
09/20/12Octanoate-reduced human albumin
06/14/12Prevention of thrombus formation and/or stabilization
02/16/12Method for the prevention and treatment of cancer by inhibition of gpvi
08/04/11Proteolytically cleavable fusion proteins with high molar specific activity
04/14/11Methods for purification of alpha-1-antitrypsin andapolipoprotein a-1
02/24/11Factor h for the treatment of chronic nephropathies and production thereof
06/25/09Mutants of the factor vii-activating protease and detection methods using specific antibodies
05/21/09Modified vitamin k dependent polypeptides
04/02/09Procedure for the determination of the activity of the protease which activates factor vii from protein solutions







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Csl Behring Gmbh in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Csl Behring Gmbh with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';